972 Shares in Chemed Co. (NYSE:CHE) Bought by Lord & Richards Wealth Management LLC

Lord & Richards Wealth Management LLC bought a new position in shares of Chemed Co. (NYSE:CHEFree Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 972 shares of the company’s stock, valued at approximately $515,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. UMB Bank n.a. lifted its stake in shares of Chemed by 300.0% in the fourth quarter. UMB Bank n.a. now owns 52 shares of the company’s stock valued at $28,000 after buying an additional 39 shares in the last quarter. Trust Co. of Vermont bought a new position in shares of Chemed in the fourth quarter valued at $34,000. Farther Finance Advisors LLC lifted its stake in shares of Chemed by 2,314.3% in the third quarter. Farther Finance Advisors LLC now owns 338 shares of the company’s stock valued at $203,000 after buying an additional 324 shares in the last quarter. KBC Group NV lifted its stake in shares of Chemed by 11.5% in the third quarter. KBC Group NV now owns 378 shares of the company’s stock valued at $227,000 after buying an additional 39 shares in the last quarter. Finally, Venturi Wealth Management LLC lifted its stake in shares of Chemed by 59.8% in the third quarter. Venturi Wealth Management LLC now owns 425 shares of the company’s stock valued at $255,000 after buying an additional 159 shares in the last quarter. 95.85% of the stock is owned by institutional investors.

Insider Activity at Chemed

In related news, VP Brian C. Judkins acquired 145 shares of the firm’s stock in a transaction that occurred on Monday, December 30th. The stock was acquired at an average price of $519.50 per share, for a total transaction of $75,327.50. Following the completion of the acquisition, the vice president now owns 1,678 shares of the company’s stock, valued at approximately $871,721. This represents a 9.46 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $572.77, for a total transaction of $1,145,540.00. Following the sale, the chief executive officer now owns 101,735 shares of the company’s stock, valued at $58,270,755.95. This trade represents a 1.93 % decrease in their position. The disclosure for this sale can be found here. 3.32% of the stock is owned by insiders.

Chemed Price Performance

CHE opened at $553.10 on Friday. The company’s 50-day moving average is $542.34 and its 200 day moving average is $564.70. Chemed Co. has a fifty-two week low of $512.12 and a fifty-two week high of $654.62. The firm has a market capitalization of $8.32 billion, a P/E ratio of 27.95, a PEG ratio of 2.16 and a beta of 0.48.

Chemed Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, March 14th. Investors of record on Monday, February 24th will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.36%. Chemed’s payout ratio is currently 10.11%.

Analyst Ratings Changes

A number of research firms have weighed in on CHE. StockNews.com raised shares of Chemed from a “hold” rating to a “buy” rating in a research note on Saturday, November 30th. Royal Bank of Canada dropped their price objective on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating on the stock in a research note on Tuesday, November 5th.

Get Our Latest Analysis on CHE

Chemed Profile

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Read More

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHEFree Report).

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.